China CAS NO 872511-35-8 Factory

Our well-equipped facilities and exceptional top quality handle throughout all stages of production enables us to guarantee total client fulfillment for CAS NO 872511-35-8,872511-35-8,Infigratinib intermediate,Infigratinib advance intermediate,N4-(4-(4-ethylpiperazin-1-yl)phenyl), We warmly welcome customers, business associations and friends from all over the world to contact us and seek cooperation for mutual benefits.
CAS NO 872511-35-8, Customer's satisfaction is always our quest, creating value for customers is always our duty, a long term mutual-beneficial business relationship is what we've been doing for. We are an absolutely reliable partner for yourself in China. Of course, other services, like consulting, can be offered too.

Hot Products

  • (S)Ibr09A

    (S)Ibr09A

    Product Name:(S)Ibr09A
    Molecular Formula:C22H23ClN6O
    Molecular Weight:422.92
    CAS Registry Number:2031255-22-6
  • Acetone thiosemicarbazone

    Acetone thiosemicarbazone

    Product Name:Acetone thiosemicarbazone
    Molecular Formula:C4H9N3S
    Molecular Weight;131.2
    CAS Registry Number;1752-30-3
  • 2,3,4,5-Tetrafluorobenzoic acid

    2,3,4,5-Tetrafluorobenzoic acid

    Product Name:2,3,4,5-Tetrafluorobenzoic acid
    Molecular Formula:C7H2F4O2
    Molecular Weight:194.08
    CAS Registry Number:1201-31-6
  • Hydrobenzole Hydrochloride

    Hydrobenzole Hydrochloride

    Product Name:Hydrobenzole Hydrochloride
    Molecular Formula:C14H13ClN2O
    Molecular Weight;260.76
    CAS Registry Number;3521-62-7
  • alpha-Methylcinnamaldehyde

    alpha-Methylcinnamaldehyde

    Product Name:alpha-Methylcinnamaldehyde
    Molecular Formula:C10H10O
    Molecular Weight:146.19
    CAS Registry Number:101-39-3
  • Ramelteon

    Ramelteon

    Product Name:Ramelteon
    Molecular Formula:C16H21NO2
    Molecular Weight;259.34
    CAS Registry Number;196597-26-9

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept